Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Lung cancer screening in the UK

David Baldwin • 29 Jan 2020
BTOG 2020
Lung Cancer
NELSON

David Baldwin, MD, FRCP, University of Nottingham, Nottingham, UK, discusses the mortality results from the NELSON screening study (ISRCTN63545820) and the current status of a national screening program in the UK. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from David Baldwin

3:36
Facilitating the decision-making process for patients during lung cancer screening
David Baldwin • 29 Aug 2023
1:33
Strategies for ensuring the cost-effectiveness of lung cancer screening in the UK
David Baldwin • 29 Aug 2023
1:32
Advancements in the UK’s national screening programme for lung cancer
David Baldwin • 29 Aug 2023
1:26
Highlights from WCLC 2022: CT screening
David Baldwin • 7 Aug 2022

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals